Total Payments
$35,704
2024 Payments
$745.61
Companies
35
Transactions
216
Medicare Patients
684
Medicare Billing
$77,367
Payment Breakdown by Category
Other$26,624 (74.6%)
Food & Beverage$5,429 (15.2%)
Travel$3,401 (9.5%)
Consulting$250.00 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $26,624 | 16 | 74.6% |
| Food and Beverage | $5,429 | 188 | 15.2% |
| Travel and Lodging | $3,401 | 11 | 9.5% |
| Consulting Fee | $250.00 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $32,197 | 56 | $0 (2023) |
| EMD Serono, Inc. | $522.34 | 6 | $0 (2024) |
| ABBVIE INC. | $508.67 | 42 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $323.55 | 12 | $0 (2024) |
| Lilly USA, LLC | $241.98 | 17 | $0 (2024) |
| Biogen, Inc. | $220.76 | 12 | $0 (2018) |
| LivaNova USA, Inc. | $205.06 | 5 | $0 (2020) |
| UCB, Inc. | $192.20 | 6 | $0 (2024) |
| PFIZER INC. | $168.42 | 11 | $0 (2024) |
| Allergan, Inc. | $136.45 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $745.61 | 23 | EMD Serono, Inc. ($250.52) |
| 2023 | $784.76 | 22 | EMD Serono, Inc. ($271.82) |
| 2022 | $697.81 | 44 | ABBVIE INC. ($250.65) |
| 2021 | $6,694 | 27 | Teva Pharmaceuticals USA, Inc. ($6,375) |
| 2020 | $3,854 | 12 | Teva Pharmaceuticals USA, Inc. ($3,610) |
| 2019 | $8,836 | 26 | Teva Pharmaceuticals USA, Inc. ($8,254) |
| 2018 | $13,758 | 45 | Teva Pharmaceuticals USA, Inc. ($13,571) |
| 2017 | $333.76 | 17 | Biogen, Inc. ($174.21) |
All Payment Transactions
216 individual payment records from CMS Open Payments — Page 3 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $28.17 | General |
| 11/15/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Neuroscience | ||||||
| 11/10/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: PRIMARY CARE | ||||||
| 10/31/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: HYPERHYDROSIS | ||||||
| 10/18/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Neuroscience | ||||||
| 10/17/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.99 | General |
| Category: PRIMARY CARE | ||||||
| 09/29/2022 | Neurocrine Biosciences, Inc. | Ongentys (Drug), INGREZZA | Food and Beverage | In-kind items and services | $22.97 | General |
| Category: Neuropsychiatry | ||||||
| 09/22/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/21/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/20/2022 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.78 | General |
| 09/19/2022 | Lilly USA, LLC | EMGALITY (Drug), AMYVID, REYVOW | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Neuroscience | ||||||
| 08/23/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Neuroscience | ||||||
| 08/11/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.45 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/09/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: PRIMARY CARE | ||||||
| 08/01/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $2.84 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug), Ongentys | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Neuropsychiatry | ||||||
| 07/12/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $12.25 | General |
| Category: Neuroscience | ||||||
| 07/05/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $8.55 | General |
| Category: NEUROSCIENCE | ||||||
| 06/22/2022 | Biohaven Pharmaceutical Holding Company Ltd. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $25.93 | General |
| Category: PRIMARY CARE | ||||||
| 06/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 06/15/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: HYPERHYDROSIS | ||||||
| 06/13/2022 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 129 | 184 | $42,249 | $16,128 |
| 2022 | 4 | 237 | 280 | $64,654 | $26,927 |
| 2021 | 5 | 162 | 226 | $42,901 | $18,678 |
| 2020 | 3 | 156 | 200 | $44,927 | $15,633 |
Total Patients
684
Total Services
890
Medicare Billing
$77,367
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 141 | $28,861 | $11,144 | 38.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 23 | 29 | $7,934 | $2,988 | 37.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $5,454 | $1,996 | 36.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 150 | $30,508 | $12,438 | 40.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 57 | 60 | $16,128 | $7,917 | 49.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $15,127 | $5,550 | 36.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 21 | $2,891 | $1,021 | 35.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 142 | $29,110 | $12,612 | 43.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $8,532 | $3,407 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 29 | $4,031 | $1,667 | 41.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 12 | 12 | $748.00 | $742.08 | 99.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $480.00 | $249.92 | 52.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 72 | 112 | $22,960 | $8,604 | 37.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 55 | 55 | $17,380 | $5,249 | 30.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 33 | $4,587 | $1,780 | 38.8% |
About Dr. Karla Ledoux, DO
Dr. Karla Ledoux, DO is a Neurology healthcare provider based in Lakeland, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1760440341.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Karla Ledoux, DO has received a total of $35,704 in payments from pharmaceutical and medical device companies, with $745.61 received in 2024. These payments were reported across 216 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($26,624).
As a Medicare-enrolled provider, Ledoux has provided services to 684 Medicare beneficiaries, totaling 890 services with total Medicare billing of $77,367. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Neurology
- Location Lakeland, FL
- Active Since 05/03/2006
- Last Updated 09/21/2023
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1760440341
Products in Payments
- AJOVY (Drug) $16,982
- AJOVY (Biological) $10,081
- UBRELVY (Drug) $277.35
- MAVENCLAD (Drug) $271.82
- Austedo XR (Drug) $236.40
- EMGALITY (Drug) $227.37
- NURTEC ODT (Drug) $209.60
- VNS Therapy (Device) $205.06
- TECFIDERA (Drug) $171.93
- AUSTEDO (Drug) $156.71
- Rystiggo (Drug) $150.91
- QULIPTA (Drug) $147.31
- Aimovig (Biological) $124.97
- Mavenclad (Drug) $119.82
- BOTOX (Drug) $112.99
- BOTOX (Biological) $107.47
- PAXLOVID (Drug) $77.15
- Gamunex-C (Biological) $76.02
- NUPLAZID (Drug) $58.24
- SD809-TD (Drug) $53.61
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lakeland
Niraja Suresh, M.d, M.D
Neurology — Payments: $94,432
Neurology $94,432
Zuleyma Toledo-Nieves
Neurology — Payments: $83,197
Neurology $83,197
Daniel Traviesa, Md, MD
Neurology — Payments: $17,141
Neurology $17,141
Daynet Hisley, Md, MD
Neurology — Payments: $14,647
Neurology $14,647
Dr. Herminio Cuervo-Delgado, M.d, M.D
Neurology — Payments: $8,088
Neurology $8,088
John Dilullo, Md, MD
Neurology — Payments: $4,437
Neurology $4,437